DJIA 17,555.70 115.11 0.66%
NASDAQ 5,062.92 23.14 0.46%
S&P 500 2,082.82 15.18 0.73%
market minute promo

BioMarin Pharmaceutical (NASDAQ: BMRN)

144.07 -0.25 (-0.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $144.07 -0.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $144.93
Previous Close $144.32
Daily Range $142.21 - $145.01
52-Week Range $59.10 - $151.75
Market Cap $23.1B
P/E Ratio -134.88
Dividend (Yield) $0.00 (0.0%)
Volume 383,731
Average Daily Volume 1,533,901
Current FY EPS -$2.15

Sector

Healthcare

Industry

Drug Makers

BioMarin Pharmaceutical (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary

This Orphan Drugmaker Deserves a Spot on Your Radar

Orphan drug maker BioMarin has been a terrific stock for long-term investors, but is its pipeline strong enough to continue to propel the stock higher?

With The Teva Money, Allergan Could Engage In 'Large M&A' Next: Evercore ISI

After Hours Most Active for Jul 24, 2015 : NTCT, QQQ, TDW, T, BMRN, AAPL, UTX^A, GE, NE, CSCO, PLCM

After Hours Most Active for Jul 24, 2015 : NTCT, QQQ, TDW, T, BMRN, AAPL, UTX^A, GE, NE, CSCO, PLCM, RDN

BioMarin Provides Update on Phase II Talazoparib Study - Analyst Blog

FDA Closing In on November Expert Panel Date for BioMarin, Sarepta Drugs

Noteworthy ETF Inflows: VXF, ILMN, LNKD, BMRN

4 Large Cap Biotech Stocks to Buy Before Earnings

3 Soaring Clinical-Stage Biotechs, and 1 to Buy

One Motley Fool digs into three top performing biotech stocks and discovers one that may still be worth buying.

Short Sellers Shy Away From Biotech Stocks

BioMarin Pharmaceutical (BMRN) Stock is the ‘Chart of the Day’

See More BMRN News...

BMRN's Top Competitors

BMRN $144.07 (-0.17%)
Current stock: BMRN
AMGN $171.84 (3.81%)
Current stock: AMGN
GILD $111.57 (0.93%)
Current stock: GILD
BIIB $313.75 (1.40%)
Current stock: BIIB